Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans he has to make available on the NHS the drug BAN2401 for the prevention of Alzheimers.

We are aware that this drug, BAN2401 which is currently the subject of early clinical trials to test its efficacy and safety, does not have a marketing authorisation and is not routinely funded by the National Health Service. Following successful clinical trials, the company would be able to apply for a marketing authorisation for the product and it will be considered through the established topic selection arrangements for potential guidance development by the National Institute for Health and Care Excellence.